Press contact: Helen Dalrymple (202) 707-1940
Public contact: Elizabeth Sherman (202) 707-0235
Request ADA accommodations in advance at (202) 707-6362

May 3, 2005

MEDIA ADVISORY

Discussion of Neuroethics To Be Held on May 10-11

WHAT: Day-and-a-half invitational scholarly discussion titled "Hard Science, Hard Choices: Facts, Ethics & Policies Guiding Brain Science Today" to explore new and emerging technologies; to explore the ethical, societal, economic and legal implications of these technologies; to examine the implications for public policy; and to share research and findings in the emerging field of neuroethics.

WHEN: 8 a.m. to 9 p.m. on Tuesday, May 10; 8 a.m. to 1 p.m. on Wednesday, May 11

WHERE: Whittall Pavilion, ground floor of the Thomas Jefferson Building, 10 First St. S.E., Washington, D.C.

(Members of the media are welcome to attend all sessions.)

PROGRAM

Tuesday, May 10

8 a.m. Continental breakfast

8:45 a.m. WELCOME

Ruth Fischbach, director, Center for Bioethics, Columbia University College of Physicians and Surgeons

9 a.m. OVERVIEW: NEUROIMAGING

State of the art and future prospects

Marcus Raichle, professor of radiology, neurology, anatomy and neurobiology, Washington University School of Medicine

9:45 a.m. PANEL 1: USES AND ABUSES OF THE VISIBLE BRAIN

Panelist presentations

Judy Illes, director, Program in Neuroethics, Center for Biomedical Ethics, Stanford University, Moderator

Adina Roskies, assistant professor of philosophy, Dartmouth College

Daniel Schachter, William R. Kenan Jr. Professor of Psychology, Harvard University

Joy Hirsch, professor of cognitive systems and neurobiology, Center for Neurobiology and Behavior, Columbia University

Discussants

Stacey Tovino, Institute for the Medical Humanities graduate program, Health Law & Policy Institute, University of Houston

Paul Root Wolpe, professor of psychiatry, medical ethics and sociology, director, Program in Psychiatry and Ethics, University of Pennsylvania School of Medicine

Martha Farah, director, Center for Cognitive Neuroscience, University of Pennsylvania

12:30 p.m. LUNCH in LJ 119, first floor of the Jefferson Building

1:45 p.m. OVERVIEW: NEUROTECHNOLOGY

State of the art and future prospects

Andres Lozano, Ronald R. Tasker Chair in Functional Neurosurgery, University Health Network, University of Toronto

John Donaghue, professor of neuroscience, Brown University

2:45 p.m. PANEL 2: TECHNOLOGY FOR THE BRAIN FROM ROBOTS TO NANOPROBES

Panelist presentations

Mahlon DeLong, chairman, Department of Neurology, Emory University School of Medicine, Moderator

Robert Goodman, assistant professor of neurosurgery, Columbia Presbyterian Medical Center

Dennis D. Spencer, professor and chairman, Department of Neurosurgery, and director of the Epilepsy Program, Yale Medical Group

William J. Heetderks, director, Extramural Science Programs, National Institute of Biomedical Imaging & Bioengineering

Discussants

Mary Faith Marshall, professor, Center for Bioethics and associate dean, School of Medicine, University of Minnesota

Paul Root Wolpe

5:30 p.m. KEYNOTE EVENT in LJ 119 of the Jefferson Building

William Safire, chairman of the Dana Foundation, moderates a discussion between Michael Gazzaniga, author and neuroscientist at Dartmouth College, and Henry Greely, professor of law, Stanford University (This event is open to the public)

7 p.m. Reception and dinner in Montpelier Room, sixth floor of the Madison Building

PROGRAM

Wednesday, May 11

8 a.m. Continental breakfast

8:45 a.m. PSYCHO-PHARMACEUTICALS

State of the art and future prospects

Steven Hyman, provost, Harvard University

9:30 a.m. PANEL 3: PSYCHOPHARMACOLOGY AND THE THERAPY/ENHANCEMENT DISTINCTION

Panelist presentations

Martha Farah, Moderator

Benedetto Vitiello, chief, Child & Adolescent Treatment and Preventive Intervention Research Branch, National Institute of Mental Health

Daniel Weinberger, director, Genes, Cognition and Psychosis Program, Intramural Research Program, National Institute of Mental Health

Russell Katz, director, Division of Neuropharmacological Drugs, Food and Drug Administration

Discussants

Anjan Chatterjee, associate professor of neurology, University of Pennsylvania

Jonathan Moreno, director, Center for Biomedical Ethics, University of Virginia Health System

Thomas Murray, president, The Hastings Center

Noon LUNCH in LJ 119, first floor of the Jefferson Building

12:45 p.m. CLOSING REMARKS

Gerald Fischbach, executive vice president for Health and Biomedical Sciences, Columbia University College of Physicians and Surgeons

# # #

PR 05-114
05/03/05
ISSN 0731-3527

Back to top